期刊文献+

磁共振成像与前列腺癌诊断以及肿瘤恶性程度的相关性分析 被引量:12

Correlation of MRI image with the diagnosis of prostate cancer and tumor malignancy grade
原文传递
导出
摘要 目的评估磁共振成像(MRI)影像结果与前列腺癌检出率及肿瘤恶性程度的相关性。方法回顾性分析北京医院泌尿外科前列腺特异性抗原(PSA)20μg/L以下患者前列腺穿刺活检资料,比较MRI结果与肿瘤检出率、Gleason评分以及肿瘤转移的相关性。结果本组218例患者,经穿刺活检诊断前列腺癌88例(40.4%)。MRI阳性患者126例,穿刺阳性结果73例(57.9%);MRI阴性患者92例,穿刺阳性结果15例(16.3%)。MRI对于前列腺癌诊断的敏感性82.95%,特异性58.78%,阳性预测值57.94%,阴性预测值83.70%。MRI对于前列腺癌诊断的受试者工作特征(ROC)曲线下面积为0.709。MRI结果与Gleason评分有相关性。结论在PSA20μg/L以下的患者中,MRI影像结果与前列腺癌检出率、肿瘤Gleason评分相关。 Objective To evaluate the correlation of MRI image with the detection rate of prostate cancer and cancer malignancy grade. Methods The prostate biopsy data of patients with prostate specific antigen (PSA) less than 20 μg/L were retrospectively analyzed. The correlations of MRI results with the cancer detection rate, Gleason score and tumor metastasis were analyzed and compared. Results Of 218 cases, 88 prostate cancer patients (40.4%) were detected out by prostate puncture biopsy. In 126 MRI-positive prostate cancer patients, the detection rate of prostate cancer by prostate puncture biopsy was 57.9% (73 cases). In 92 MRI-negative prostate cancer patients,the detection rate of prostate cancer by prostate puncture biopsy was 16.3% (15 cases). The sensitivity, specificity, positive prognostic rate and negative prognostic rate by MRI were 82.95%, 58.78%, 57.94% and 83.70%, respectively. The area under receiver operating characteristic (ROC) curve for MRI to predict prostate cancer was 0. 709. MRI results had a correlation with Gleason score. Conclusions MRI image has significant correlation with prostate cancer detection rate and Gleason score in patients with PSA less than 20μg/L.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2016年第8期846-849,共4页 Chinese Journal of Geriatrics
关键词 前列腺肿瘤 磁共振成像 活组织检查 针吸 Prostate neoplasms Magnetic resonance imaging Biopsy, needle
  • 相关文献

参考文献12

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013[J]. CA Cancer J Clin, 2013, 63 (1): 11- 30.
  • 2Epstein JI, Allsbrook WC, Amin MB, et al. ISUP Grading Committee. The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma[J]. Am J SurgPathol,2005,29(9):1228-1242.
  • 3Schiebler MI, Schnall MD, Pollack HM, et al. Current role of MR imaging in the staging of adenocarcinoma of the prostate[J]. Radiology, 1993, 189 ( 2 ): 339-352.
  • 4王萱,刘明,陈敏,李春媚,万奔,魏东,王建业.盆腔磁共振T2加权像前列腺外周带影像特征对PSA〈20μg/L前列腺癌诊断的意义[J].中华泌尿外科杂志,2013,34(4):292-297. 被引量:27
  • 5BarentszJO, Richenberg J, Clements R, et al. ESUR prostate MR guidelines 2012[J]. Eur Radiol, 2012, 22 (4): 746-757.
  • 6Schimmoller L, Quentin M, Arsov C, et al. Predicitive power of the ESUR scoring system for prostate cancer diagnosis verified with targeted MR- guided in-bore biopsy[J]. Eur Urol, 2014 , 83 (12) : 2103-2108.
  • 7Baur AD, Maxeiner A, Franiel T, et al. Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate[J]. Invest Radiol, 2014, 49 ( 11 ): 411-420.
  • 8Graser A, Heuck A, Sommer B, el al. Per-sextant localization and staging of prostate cancer:correlation imaging findings with whole-mount step section histopathology[J]. AIR Am J Roentgenol, 2007,188 (1) :84-90.
  • 9Haider MA. vail der Kwast TH, Tanguay J, et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer [J]. AJR Am J Roentgen,2007,189(2) :323-328.
  • 10Klein EA. What is insignificant prostate carcinoma [J]. Cancer, 2004, 101(9) :1923-1925.

二级参考文献18

  • 1Dickinson L, Ahmed HU, Allen C, et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Ear Urol, 2011, 59: 477-494.
  • 2Epstein JI, Allsbrook WC Jr, Amin MB, et al. ISUP Grading Committee. The 2005 International Society of Urological Patholo- gy (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol, 2005, 29 : 1228-1242.
  • 3Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin, 2010, 60: 277-300.
  • 4Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin, 2009, 59 : 225-249.
  • 5Amsellem-Ouazana D, Younes P, Coquy S, et al. Negative pros- tatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectros- copy imaging (MRSI) a useful tool. A preliminary study. Eur Urol, 2005, 47: 582-586.
  • 6Barentsz JO, Richenberg J, Clements R, et al. ESUR prostate MR guidelines 2012. Eur Radiol, 2012 , 22: 746-757.
  • 7Graser A, Heuck A, Sommer B, et al. Per-sextant localization and staging of prostate cancer: correlation of imaging findings with whole-mount step section histopathology. A JR Am J lRoent- genol, 2007, 188 : 84-90.
  • 8Haider MA, van der Kwast TH, Tanguay J, et al. Combined T2- weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol, 2007, 189: 323-328.
  • 9Kitajima K, Kaji Y, Fakabori Y, et al. Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dy- namic contrast-enhanced MRI in combination with T2-weighted imaging. J Magn Reson Imaging, 2010, 31 : 625-631.
  • 10Cruz M, Tsuda K, Narumi Y, et al. Characterization of low-in- tensity lesions in the peripheral zone of prostate on pre-biopsy en- dorectal coil MR imaging. Ear RadJol, 2002, 12: 357-365.

共引文献26

同被引文献99

引证文献12

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部